Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Viridian Therapeutics (GB:0K1R)
LSE:0K1R
RESEARCH TOOLSreports
Holding GB:0K1R?
Track your performance easily
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 86.00K | $ 72.00K | $ 72.00K | $ 72.00K | $ 72.00K |
| Gross Profit | $ 86.00K | $ 72.00K | $ 72.00K | $ 72.00K | $ 72.00K |
| EBIT | $ -76.69M | $ -64.99M | $ -47.95M | $ -65.94M | $ -47.06M |
| EBITDA | $ -76.49M | $ -60.06M | $ -47.81M | $ -65.79M | $ -46.92M |
| Net Income Common Stockholders | $ -76.69M | $ -64.40M | $ -48.54M | $ -66.86M | $ -47.66M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 552.92M | $ 463.70M | $ 521.55M | $ 374.54M | $ 201.41M |
| Total Assets | $ 771.90M | $ 585.66M | $ 630.38M | $ 490.42M | $ 328.76M |
| Total Debt | $ 20.52M | $ 20.45M | $ 20.33M | $ 20.20M | $ 20.00M |
| Net Debt | $ -532.40M | $ -443.25M | $ -501.22M | $ -354.34M | $ -181.41M |
| Total Liabilities | $ 64.40M | $ 56.33M | $ 47.85M | $ 48.40M | $ 45.18M |
| Stockholders Equity | $ 707.50M | $ 401.06M | $ 454.25M | $ 442.02M | $ 283.58M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -68.00M | $ -46.16M | $ -45.22M | $ -38.05M | $ -39.39M |
| Operating Cash Flow | $ -67.71M | $ -46.06M | $ -45.22M | $ -38.00M | $ -38.98M |
| Investing Cash Flow | $ -84.67M | $ 61.98M | $ -143.04M | $ -169.71M | $ 48.04M |
| Financing Cash Flow | $ 245.02M | $ 108.00K | $ 177.08M | $ 198.94M | $ 15.46M |